Treatment of paroxysmal nocturnal hemoglobinuria
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, life‑threatening clonal hematological disorder caused by an acquired mutation in the phosphatidylinositol glucan (PIG)-A gene. PNH is characterized by chronic intravascular hemolysis, marrow failure, thrombophilia and other severe clinical syndrom...
Saved in:
| Main Authors: | I. A. Lisukov, A. D. Kulagin, B. V. Afanasyev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-07-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/54 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
National clinical guidelines for the diagnosis and treatment of paroxysmal nocturnal hemoglobinuria
by: A. D. Kulagin, et al.
Published: (2014-09-01) -
Paroxysmal nocturnal hemoglobinuria: Pandora’s box?
by: Mihnea-Alexandru Găman, et al.
Published: (2020-10-01) -
Long-term effectiveness and safety of ravulizumab in paroxysmal nocturnal hemoglobinuria: a plain language summary
by: Celso Arrais, et al.
Published: (2025-07-01) -
Hematological response in patients with paroxysmal nocturnal hemoglobinuria treated with C5-inhibitor
by: V. D. Latyshev, et al.
Published: (2024-01-01) -
The Advancing Landscape of Paroxysmal Nocturnal Hemoglobinuria Treatment
by: Cameron Perry, et al.
Published: (2025-06-01)